More on ALLO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.0 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allogene Therapeutics (NQ:ALLO)
Delayed: 2.00 +0.04 (2.04%)
Prev. Close $1.96  
Open$2.02 
52 Wk High$ 
52 Wk Low$ 
Day High$2.08 
Day Low$1.97 
P/E N/A  
EPS$ 
Volume23,548,244 

Friends, Peers and Foes (?): ALCLS, CLLS, CHRS, ELVN, ONCY (more...)

May 28, 2026 05:51 PM Form DEFA14A Allogene Therapeutics,
May 28, 2026 05:50 PM Form 8-K Allogene Therapeutics, For: May 28
May 28, 2026 05:06 PM Allogene Therapeutics announces CEO succession plan
May 28, 2026 05:02 PM Allogene Therapeutics Announces Planned CEO Succession
May 26, 2026 08:30 AM Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
May 21, 2026 06:02 AM Form DEFA14A Allogene Therapeutics,
May 15, 2026 04:51 PM Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: CITADEL ADVISORS LLC
May 15, 2026 04:39 PM Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Lynx1 Capital Management LP
May 13, 2026 07:12 PM Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie
May 13, 2026 04:56 PM Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Chang David D
View All Articles

Entities mentioned with ALLO

View All Entities